Literature DB >> 29067592

Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.

Kuan-Hui Hsu1, Karishma Gupta1, Harish Nayaka1, Aashrit Donthi1, Siddarth Kaul1, Anuj Chauhan2.   

Abstract

PURPOSE: About 70% of eye drops contain benzalkonium chloride (BAK) to maintain sterility. BAK is an effective preservative but it can cause irritation and toxicity. We propose to mitigate ocular toxicity without compromising sterility by incorporating a filter into an eye drop bottle to selectively remove BAK during the process of drop instillation.
METHODS: The filter is a packed bed of particles made from poly(2-hydroxyethyl methacrylate) (pHEMA), which is a common ophthalmic material. We showed that pHEMA particle prepared by using ethoxylated trimethylolpropane triacrylate as crosslinker can be incorporated into a modified eyedrop bottle tip to selectively remove the preservative as the formulation is squeezed out of the bottle. Hydraulic permeability of the plug is measured to determine the resistance to eye drop squeezing, and % removal of BAK and drugs are determined.
RESULTS: The modified tip has a hydraulic permeability of about 2 Darcy, which allows eyedrops formulations to flow through without excessive resistance. The tip is designed such that the patients can create an eyedrop of solution of 1-10 cP viscosity in 4 s with a nominal pressure. During this short contact time, the packed particles removed nearly 100% of benzalkonium chloride (BAK) from a 15 mL, 0.012% BAK solution but have only minimal impact on the concentration of contained active components.
CONCLUSION: Our novel design can eliminate the preservative induced toxicity from eye drops thereby impacting hundreds of millions of patients with chronic ophthalmic diseases like glaucoma and dry eyes.

Entities:  

Keywords:  benzalkonium chloride; eye drops; hydraulic permeability; poly(2-hydroxyethyl methacrylate); preservative-free; selectivity of separation

Mesh:

Substances:

Year:  2017        PMID: 29067592     DOI: 10.1007/s11095-017-2270-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers.

Authors:  M S Kim; C Y Choi; J M Kim; H R Chang; H R Chung; H Y Woo
Journal:  Br J Ophthalmol       Date:  2008-09-09       Impact factor: 4.638

2.  Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Authors:  C Baudouin; C de Lunardo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

3.  Hydrogels in endovascular embolization. I. Spherical particles of poly(2-hydroxyethyl methacrylate) and their medico-biological properties.

Authors:  D Horák; F Svec; J Kálal; K Gumargalieva; A Adamyan; N Skuba; M Titova; N Trostenyuk
Journal:  Biomaterials       Date:  1986-05       Impact factor: 12.479

4.  Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: an immunohistochemical and ultrastructural study.

Authors:  R Nuzzi; A Vercelli; C Finazzo; C Cracco
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-03       Impact factor: 3.117

5.  Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.

Authors:  Kuan-Hui Hsu; Blanca E Carbia; Caryn Plummer; Anuj Chauhan
Journal:  Eur J Pharm Biopharm       Date:  2015-06-10       Impact factor: 5.571

6.  Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels.

Authors:  Jinah Kim; Anuj Chauhan
Journal:  Int J Pharm       Date:  2007-12-08       Impact factor: 5.875

Review 7.  Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma.

Authors:  Christophe Baudouin
Journal:  Acta Ophthalmol       Date:  2008-06-03       Impact factor: 3.761

8.  Preservative-free ocular hydrating agents in symptomatic contact lens wearers: saline versus PVP solution.

Authors:  Florence Malet; Dominique Karsenti; Pascale Pouliquen
Journal:  Eye Contact Lens       Date:  2003-01       Impact factor: 2.018

9.  [The COMOD system. A preservative-free multidose container for eyedrops].

Authors:  C Teping; B Wiedemann
Journal:  Klin Monbl Augenheilkd       Date:  1994-10       Impact factor: 0.700

10.  Ocular symptoms and signs with preserved and preservative-free glaucoma medications.

Authors:  N Jaenen; C Baudouin; P Pouliquen; G Manni; A Figueiredo; T Zeyen
Journal:  Eur J Ophthalmol       Date:  2007 May-Jun       Impact factor: 2.597

View more
  4 in total

1.  An Evaluation of the Physicochemical Properties of Preservative-Free 0.005% (w/v) Latanoprost Ophthalmic Solutions, and the Impact on In Vitro Human Conjunctival Goblet Cell Survival.

Authors:  Josefine C Freiberg; Anne Hedengran; Steffen Heegaard; Goran Petrovski; Jette Jacobsen; Barbara Cvenkel; Miriam Kolko
Journal:  J Clin Med       Date:  2022-05-31       Impact factor: 4.964

2.  Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride.

Authors:  Anton G Rogov; Tatyana N Goleva; Evgeniya I Sukhanova; Khoren K Epremyan; Tatiana A Trendeleva; Alexandra P Ovchenkova; Dinara A Aliverdieva; Renata A Zvyagilskaya
Journal:  Oxid Med Cell Longev       Date:  2020-02-10       Impact factor: 6.543

Review 3.  Ocular benzalkonium chloride exposure: problems and solutions.

Authors:  Michael H Goldstein; Fabiana Q Silva; Nysha Blender; Trung Tran; Srilatha Vantipalli
Journal:  Eye (Lond)       Date:  2021-07-14       Impact factor: 4.456

4.  Formation of Drug-Participating Catanionic Aggregates for Extended Delivery of Non-Steroidal Anti-Inflammatory Drugs from Contact Lenses.

Authors:  Cesar Torres-Luna; Abdollah Koolivand; Xin Fan; Niti R Agrawal; Naiping Hu; Yuli Zhu; Roman Domszy; Robert M Briber; Nam Sun Wang; Arthur Yang
Journal:  Biomolecules       Date:  2019-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.